Responses
Clinical pharmacy
CP-169 Influence of concomitant treatment with statins on survival outcomes of patients with metastatic castration resistant prostate cancer receiving abiraterone as firstline therapy
Compose a Response to This Article
Other responses
No responses have been published for this article.